Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796674 · ClinicalTrials.gov registry record
Clareon IOL Retrospective Data Collection
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 1,090
- Enrollment target
NCT05796674 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 1,090 participants.
The verdict
NCT05796674 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 1,090 participants
- Enrollment target
Study Summary
The purpose of this study is to provide real world evidence (RWE) on the performance of the Clareon ultraviolet absorbing (UVA) intraocular lenses (IOLs) to support the overall body of evidence on the Clareon IOL family.
Interventions
- PROCEDURE Cataract surgery
- DEVICE Clareon UVA IOL
- DEVICE WaveTec Optiwave Refractive Analysis (ORA) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,090 participants |
| Start Date | 2023-08-18 |
| Est. Completion | 2023-09-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05796674
The ClinicalTrials.gov registry entry for NCT05796674 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,090 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cataract surgery is the first listed.
NCT05796674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05796674 about?
NCT05796674 is a clinical study titled "Clareon IOL Retrospective Data Collection". The purpose of this study is to provide real world evidence (RWE) on the performance of the Clareon ultraviolet absorbing (UVA) intraocular lenses (IOLs) to support the overall body of evidence on the Clareon IOL family.
What is the current status of trial NCT05796674?
This trial is currently completed. The enrollment target is 1,090 participants. The study started on 2023-08-18. Estimated completion is 2023-09-12.
What interventions are being tested in trial NCT05796674?
The interventions under investigation include: Cataract surgery (PROCEDURE), Clareon UVA IOL (DEVICE), WaveTec Optiwave Refractive Analysis (ORA) System (DEVICE).
Who is sponsoring clinical trial NCT05796674?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.